Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Value of Hemato-immunological Profile in ITP
NCT04070599Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Apr 2011
- Primary completion
- Mar 2014
- Countries
- 1
01
Overview
Phase 3, single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Complete Remission at 12 months. Started Apr 2011; status: completed.
Beyond the preview
Go deeper on NCT04070599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04070599.